Prostaglandin E₂ synthase inhibition as a therapeutic target

Bibliography

• Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231(25):232-5
   PubMedGoogle Scholar
• Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259(2):315-24
   PubMed Web of Science ®Google Scholar
• Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 1984;2:335-57
   PubMed Web of Science ®Google Scholar
• Komers R, Epstein M. Cyclooxygenase-2 expression and function in renal pathophysiology. J Hypertens Suppl 2002;20(6):S11-5
   Google Scholar
• McAdam BF, Mardini IA, Habib A, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest 2000;105(10):1473-82
   PubMed Web of Science ®Google Scholar
• Yamagata K, Andreasson KI, Kaufmann WE, et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993;11(2):371-86
   PubMed Web of Science ®Google Scholar
• FitzGerald GA. Parsing an enigma: the pharmacodynamics of aspirin resistance. Lancet 2003;361(9357):542-4
   PubMed Web of Science ®Google Scholar
• Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996;52(Suppl 5):13-23
   PubMed Web of Science ®Google Scholar
• Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004;351(17):1709-11
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286(8):954-9
   PubMed Web of Science ®Google Scholar
• Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365(9458):475-81
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352(11):1092-102
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296(13):1633-44
   PubMed Web of Science ®Google Scholar
• Graham D. Risk of acute myocardial infarction and sudden cardiac death in patients treated with COX-2 selective and non-selective NSAIDs. Washington, DC: FDA/Center For Drug Evaluation And Research, 2004. Available from: www.fda.gov/cder/drug/infopage/vioxx/vioxxgraham.pdf [Last accessed 12 May 2009]
   Google Scholar
• Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999;96(13):7220-5
   PubMed Web of Science ®Google Scholar
• Per-Johan Jakobsson BS, Ralf Morgenstern, Anthony Ford-Hutchinson, Joseph Mancini, inventor Karolinska Innovations AB, assignee. Methods and means for modulating PGE synthase activity. US7192733; 2007;
   Google Scholar
• Zeilhofer HU, Brune K. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 2006;27(9):467-74
   PubMed Web of Science ®Google Scholar
• Jakobsson PJ, Morgenstern R, Mancini J, et al. Common structural features of MAPEG – a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci 1999;8(3):689-92
   PubMed Web of Science ®Google Scholar
• Tanikawa N, Ohmiya Y, Ohkubo H, et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 2002;291(4):884-9
   PubMed Web of Science ®Google Scholar
• Tanioka T, Nakatani Y, Semmyo N, et al. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000;275(42):32775-82
   PubMed Web of Science ®Google Scholar
• Thoren S, Weinander R, Saha S, et al. Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J Biol Chem 2003;278(25):22199-209
   PubMed Web of Science ®Google Scholar
• Kudo I, Murakami M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 2005;38(6):633-8
   PubMedGoogle Scholar
• Ouellet M, Falgueyret JP, Ear PH, et al. Purification and characterization of recombinant microsomal prostaglandin E synthase-1. Protein Expr Purif 2002;26(3):489-95
   PubMedGoogle Scholar
• Mancini JA, Blood K, Guay J, et al. Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J Biol Chem 2001;276(6):4469-75
   PubMed Web of Science ®Google Scholar
• Stark K, Bylund J, Torma H, et al. On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and expression of cyclooxygenase-2, PGH 19-hydroxylase (CYP4F8) and microsomal PGE synthase-1 in seminal vesicles and vas deferens. Prostaglandins Other Lipid Mediat 2005;75(1-4):47-64
   PubMedGoogle Scholar
• Fuson AL, Komlosi P, Unlap TM, et al. Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney. Am J Physiol Renal Physiol 2003;285(3):F558-64
   Google Scholar
• Murakami M, Nakashima K, Kamei D, et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 2003;278(39):37937-47
   PubMed Web of Science ®Google Scholar
• Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000;275(42):32783-92
   PubMed Web of Science ®Google Scholar
• Vazquez-Tello A, Fan L, Hou X, et al. Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain. Am J Physiol Regul Integr Comp Physiol 2004;287(5):R1155-63
   Google Scholar
• Chandrasekharan S, Foley NA, Jania L, et al. Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland. J Lipid Res 2005;46(12):2636-48
   PubMedGoogle Scholar
• Schneider A, Zhang Y, Zhang M, et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney Int 2004;65(4):1205-13
   PubMedGoogle Scholar
• Kozak KR, Crews BC, Morrow JD, et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 2002;277(47):44877-85
   PubMed Web of Science ®Google Scholar
• Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006;119(3):229-40
   PubMed Web of Science ®Google Scholar
• Ekstrom L, Lyrenas L, Jakobsson PJ, et al. Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3. Biochim Biophys Acta 2003;1627(2-3):79-84
   PubMedGoogle Scholar
• Cheng S, Afif H, Martel-Pelletier J, et al. Activation of peroxisome proliferator-activated receptor γ inhibits interleukin-1β-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem 2004;279(21):22057-65
   PubMed Web of Science ®Google Scholar
• Jania LA, Chandrasekharan S, Backlund MG, et al. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat 2009;88(3-4):73-81
   PubMed Web of Science ®Google Scholar
• Johnson JL, Beito TG, Krco CJ, Toft DO. Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes. Mol Cell Biol 1994;14(3):1956-63
   PubMed Web of Science ®Google Scholar
• Smith DF, Faber LE, Toft DO. Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins. J Biol Chem 1990;265(7):3996-4003
   PubMedGoogle Scholar
• Kobayashi T, Nakatani Y, Tanioka T, et al. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J 2004;381(Pt 1):59-69
   PubMed Web of Science ®Google Scholar
• Lovgren AK, Kovarova M, Koller BH. cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis. Mol Cell Biol 2007;27(12):4416-30
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Hokonohara Y, Kakuta S, et al. Knockout mice lacking cPGES/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal. Biochem Biophys Res Commun 2007;362(2):387-92
   PubMedGoogle Scholar
• Bresell A, Weinander R, Lundqvist G, et al. Bioinformatic and enzymatic characterization of the MAPEG superfamily. FEBS J 2005;272(7):1688-703
   PubMed Web of Science ®Google Scholar
• Jegerschold C, Pawelzik SC, Purhonen P, et al. Structural basis for induced formation of the inflammatory mediator prostaglandin E2. Proc Natl Acad Sci USA 2008;105(32):11110-5
   PubMed Web of Science ®Google Scholar
• Xing L, Kurumbail RG, Frazier RB, et al. Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions. J Comput Aided Mol Des 2009;23(1):13-24
   PubMedGoogle Scholar
• Forsberg L, Leeb L, Thoren S, et al. Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS Lett 2000;471(1):78-82
   PubMedGoogle Scholar
• Sampey AV, Monrad S, Crofford LJ. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther 2005;7(3):114-7
   PubMed Web of Science ®Google Scholar
• Naraba H, Yokoyama C, Tago N, et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 2002;277(32):28601-8
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Yoshimatsu K, Scherl E, et al. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 2004;279(13):12647-58
   PubMed Web of Science ®Google Scholar
• Moon Y, Lee M, Yang H. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Biochem Pharmacol 2007;73(1):125-35
   PubMed Web of Science ®Google Scholar
• Li X, Afif H, Cheng S, et al. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. J Rheumatol 2005;32(5):887-95
   PubMed Web of Science ®Google Scholar
• Bianchi A, Moulin D, Sebillaud S, et al. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)γ agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1β-stimulated rat chondrocytes: evidence for PPARγ-independent inhibition by 15-deoxy-Δ12,14prostaglandin J2. Arthritis Res Ther 2005;7(6):R1325-37
   PubMed Web of Science ®Google Scholar
• Kojima F, Naraba H, Sasaki Y, et al. Prostaglandin E2 is an enhancer of interleukin-1β-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Arthritis Rheum 2003;48(10):2819-28
   PubMedGoogle Scholar
• Kojima F, Kato S, Kawai S. Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol 2005;19(3):255-61
   PubMed Web of Science ®Google Scholar
• Sandee D, Sivanuntakorn S, Vichai V, et al. Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell lines. Prostaglandins Other Lipid Mediat 2009;88(3-4):111-6
   PubMedGoogle Scholar
• Guan Y, Zhang Y, Schneider A, et al. Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthase. Am J Physiol Renal Physiol 2001;281(6):F1173-7
   Google Scholar
• Boulet L, Ouellet M, Bateman KP, et al. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J Biol Chem 2004;279(22):23229-37
   PubMed Web of Science ®Google Scholar
• Dieter P, Scheibe R, Jakobsson PJ, et al. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages. Biochem Biophys Res Commun 2000;276(2):488-92
   PubMedGoogle Scholar
• Westman M, Korotkova M, af Klint E, et al. Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum 2004;50(6):1774-80
   PubMed Web of Science ®Google Scholar
• Kojima F, Naraba H, Sasaki Y, et al. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J Rheumatol 2002;29(9):1836-42
   PubMed Web of Science ®Google Scholar
• Claveau D, Sirinyan M, Guay J, et al. Microsomal prostaglandin E synthase-1 Is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J Immunol 2003;170(9):4738-44
   PubMed Web of Science ®Google Scholar
• Caughey GE, Cleland LG, Penglis PS, et al. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001;167(5):2831-8
   PubMedGoogle Scholar
• Uracz W, Uracz D, Olszanecki R, Gryglewski RJ. Interleukin 1β induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J Physiol Pharmacol 2002;53(4 Pt 1):643-54
   PubMedGoogle Scholar
• Yucel-Lindberg T, Hallstrom T, Kats A, et al. Induction of microsomal prostaglandin E synthase-1 in human gingival fibroblasts. Inflammation 2004;28(2):89-95
   PubMedGoogle Scholar
• Kojima F, Naraba H, Miyamoto S, et al. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res Ther 2004;6(4):R355-65
   PubMed Web of Science ®Google Scholar
• Masuko-Hongo K, Berenbaum F, Humbert L, et al. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum 2004;50(9):2829-38
   PubMed Web of Science ®Google Scholar
• Jaulmes A, Thierry S, Janvier B, et al. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1β. FASEB J 2006;20(10):1727-9
   PubMed Web of Science ®Google Scholar
• Soler M, Camacho M, Escudero JR, et al. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res 2000;87(6):504-7
   PubMedGoogle Scholar
• Degousee N, Angoulvant D, Fazel S, et al. c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. J Biol Chem 2006;281(24):16443-52
   PubMedGoogle Scholar
• Guay J, Bateman K, Gordon R, et al. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 2004;279(23):24866-72
   PubMed Web of Science ®Google Scholar
• Philippe L, Gegout-Pottie P, Guingamp C, et al. Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 1997;273(4 Pt 2):R1550-6
   Google Scholar
• Ek M, Engblom D, Saha S, et al. Inflammatory response: pathway across the blood-brain barrier. Nature 2001;410(6827):430-1
   PubMed Web of Science ®Google Scholar
• Yamagata K, Matsumura K, Inoue W, et al. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 2001;21(8):2669-77
   PubMed Web of Science ®Google Scholar
• Engblom D, Ek M, Andersson IM, et al. Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parenchyma in adjuvant-induced arthritis. J Comp Neurol 2002;452(3):205-14
   PubMedGoogle Scholar
• Moore AH, Olschowka JA, O'Banion MK. Intraparenchymal administration of interleukin-1β induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brain. J Neuroimmunol 2004;148(1-2):32-40
   PubMedGoogle Scholar
• Ozaki-Okayama Y, Matsumura K, Ibuki T, et al. Burn injury enhances brain prostaglandin E2 production through induction of cyclooxygenase-2 and microsomal prostaglandin E synthase in cerebral vascular endothelial cells in rats. Crit Care Med 2004;32(3):795-800
   PubMed Web of Science ®Google Scholar
• Turrin NP, Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis 2004;16(2):321-34
   PubMedGoogle Scholar
• Ikeda-Matsuo Y, Ikegaya Y, Matsuki N, et al. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J Neurochem 2005;94(6):1546-58
   PubMedGoogle Scholar
• Satoh K, Nagano Y, Shimomura C, et al. Expression of prostaglandin E synthase mRNA is induced in beta-amyloid treated rat astrocytes. Neurosci Lett 2000;283(3):221-3
   PubMedGoogle Scholar
• Schuligoi R, Ulcar R, Peskar BA, Amann R. Effect of endotoxin treatment on the expression of cyclooxygenase-2 and prostaglandin synthases in spinal cord, dorsal root ganglia, and skin of rats. Neuroscience 2003;116(4):1043-52
   PubMedGoogle Scholar
• Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability. Circulation 2001;104(8):921-7
   PubMed Web of Science ®Google Scholar
• Gomez-Hernandez A, Martin-Ventura JL, Sanchez-Galan E, et al. Overexpression of COX-2, prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-κB. Atherosclerosis 2006;187(1):139-49
   PubMed Web of Science ®Google Scholar
• Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003;108(9):1070-7
   PubMed Web of Science ®Google Scholar
• Camacho M, Gerboles E, Escudero JR, et al. Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E2 biosynthesis in vascular smooth muscle cells. J Thromb Haemost 2007;5(7):1411-9
   PubMedGoogle Scholar
• Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94(7):3336-40
   PubMed Web of Science ®Google Scholar
• DuBois R, Tsujii M, Morrow J, et al. Eicosanoid production and growth regulation in rat intestinal epithelial cells. Adv Exp Med Biol 1997;400A:487-93
   PubMedGoogle Scholar
• DuBois RN, Shao J, Tsujii M, et al. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996;56(4):733-7
   PubMed Web of Science ®Google Scholar
• Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83(3):493-501
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93(5):705-16
   PubMed Web of Science ®Google Scholar
• Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87(5):803-9
   PubMed Web of Science ®Google Scholar
• Williams CS, Tsujii M, Reese J, et al. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105(11):1589-94
   PubMed Web of Science ®Google Scholar
• Sonoshita M, Takaku K, Sasaki N, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nat Med 2001;7(9):1048-51
   PubMed Web of Science ®Google Scholar
• Yoshimatsu K, Altorki NK, Golijanin D, et al. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res 2001;7(9):2669-74
   PubMed Web of Science ®Google Scholar
• Jang TJ, Min SK, Bae JD, et al. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 2004;53(1):27-33
   PubMedGoogle Scholar
• Cohen EG, Almahmeed T, Du B, et al. Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma. Clin Cancer Res 2003;9(9):3425-30
   PubMedGoogle Scholar
• van Rees BP, Sivula A, Thoren S, et al. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer 2003;107(4):551-6
   PubMedGoogle Scholar
• Yoshimatsu K, Golijanin D, Paty PB, et al. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 2001;7(12):3971-6
   PubMedGoogle Scholar
• Kamei D, Murakami M, Nakatani Y, et al. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem 2003;278(21):19396-405
   PubMedGoogle Scholar
• Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23(7):1669-78
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Shimohama S, Koike H, et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem Biophys Res Commun 1999;254(3):582-6
   PubMed Web of Science ®Google Scholar
• Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998;87(2):319-24
   PubMed Web of Science ®Google Scholar
• Chaudhry UA, Zhuang H, Crain BJ, Dore S. Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease. Alzheimers Dement 2008;4(1):6-13
   PubMed Web of Science ®Google Scholar
• Campean V, Theilig F, Paliege A, et al. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 2003;285(1):F19-32
   Google Scholar
• Peti-Peterdi J, Komlosi P, Fuson AL, et al. Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells. J Clin Invest 2003;112(1):76-82
   PubMed Web of Science ®Google Scholar
• Komhoff M, Reinalter SC, Grone HJ, Seyberth HW. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res 2004;55(2):261-6
   PubMedGoogle Scholar
• Kabashima K, Sakata D, Nagamachi M, et al. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 2003;9(6):744-9
   PubMedGoogle Scholar
• Morteau O, Morham SG, Sellon R, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 2000;105(4):469-78
   PubMedGoogle Scholar
• Sirois J. Induction of prostaglandin endoperoxide synthase-2 by human chorionic gonadotropin in bovine preovulatory follicles in vivo. Endocrinology 1994;135(3):841-8
   PubMed Web of Science ®Google Scholar
• Sirois J, Dore M. The late induction of prostaglandin G/H synthase-2 in equine preovulatory follicles supports its role as a determinant of the ovulatory process. Endocrinology 1997;138(10):4427-34
   PubMed Web of Science ®Google Scholar
• Hizaki H, Segi E, Sugimoto Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc Natl Acad Sci USA 1999;96(18):10501-6
   PubMed Web of Science ®Google Scholar
• Kennedy CR, Zhang Y, Brandon S, et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 1999;5(2):217-20
   PubMed Web of Science ®Google Scholar
• Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997;91(2):197-208
   PubMed Web of Science ®Google Scholar
• Filion F, Bouchard N, Goff AK, et al. Molecular cloning and induction of bovine prostaglandin E synthase by gonadotropins in ovarian follicles prior to ovulation in vivo. J Biol Chem 2001;276(36):34323-30
   PubMedGoogle Scholar
• Wang X, Su Y, Deb K, et al. Prostaglandin E2 is a product of induced prostaglandin-endoperoxide synthase 2 and microsomal-type prostaglandin E synthase at the implantation site of the hamster. J Biol Chem 2004;279(29):30579-87
   PubMedGoogle Scholar
• Meadows JW, Pitzer B, Brockman DE, Myatt L. Differential localization of prostaglandin E synthase isoforms in human placental cell types. Placenta 2004;25(4):259-65
   PubMedGoogle Scholar
• Ni H, Sun T, Ding NZ, et al. Differential expression of microsomal prostaglandin E synthase at implantation sites and in decidual cells of mouse uterus. Biol Reprod 2002;67(1):351-8
   PubMedGoogle Scholar
• Alfaidy N, Sun M, Challis JR, Gibb W. Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labor. Endocrine 2003;20(3):219-25
   PubMedGoogle Scholar
• Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 2005;45(3):406-11
   PubMed Web of Science ®Google Scholar
• Uematsu S, Matsumoto M, Takeda K, Akira S. Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 2002;168(11):5811-6
   PubMed Web of Science ®Google Scholar
• Loftin CD, Trivedi DB, Tiano HF, et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA 2001;98(3):1059-64
   PubMed Web of Science ®Google Scholar
• Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 1998;246(1):7-12
   PubMedGoogle Scholar
• Trebino CE, Stock JL, Gibbons CP, et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci 2003;100(15):9044-9
   PubMed Web of Science ®Google Scholar
• Pini B, Grosser T, Lawson JA, et al. Prostaglandin E synthases in zebrafish. Arterioscler Thromb Vasc Biol 2005;25(2):315-20
   PubMedGoogle Scholar
• Wang M, Song WL, Cheng Y, Fitzgerald GA. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med 2008;263(5):500-5
   PubMedGoogle Scholar
• Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006;116(1):4-15
   PubMed Web of Science ®Google Scholar
• Cheng Y, Wang M, Yu Y, et al. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 2006;116(5):1391-9
   PubMed Web of Science ®Google Scholar
• Wang M, Lee E, Song W, et al. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 2008;117(10):1302-9
   PubMedGoogle Scholar
• Ikeda-Matsuo Y, Ota A, Fukada T, et al. Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci 2006;103(31):11790-5
   PubMed Web of Science ®Google Scholar
• Kamei D, Yamakawa K, Takegoshi Y, et al. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 2004;279(32):33684-95
   PubMed Web of Science ®Google Scholar
• Kojima F, Kapoor M, Yang L, et al. Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J Immunol 2008;180(12):8361-8
   PubMed Web of Science ®Google Scholar
• Kapoor M, Kojima F, Qian M, et al. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor γ: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem 2007;282(8):5356-66
   PubMedGoogle Scholar
• Mabuchi T, Kojima H, Abe T, et al. Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain. Neuroreport 2004;15(9):1395-8
   PubMed Web of Science ®Google Scholar
• Broom DC, Samad TA, Kohno T, et al. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 2004;124(4):891-900
   PubMed Web of Science ®Google Scholar
• Pecchi E, Dallaporta M, Jean A, et al. mPGES-1 knock-out mice are resistant to cancer-induced anorexia despite the absence of central mPGES-1 up-regulation in wild-type anorexic mice. J Neuroimmunol 2008;199(1-2):104-14
   PubMedGoogle Scholar
• Yamakawa K, Kamekura S, Kawamura N, et al. Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. Arthritis Rheum 2008;58(1):172-83
   PubMedGoogle Scholar
• Murakami M, Kudo I. Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des 2006;12(8):943-54
   PubMed Web of Science ®Google Scholar
• Koeberle A, Zettl H, Greiner C, et al. Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. J Med Chem 2008;51(24):8068-76
   PubMed Web of Science ®Google Scholar
• Koeberle A, Siemoneit U, Buehring U, et al. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 2008;326(3):975-82
   PubMed Web of Science ®Google Scholar
• Degousee N, Fazel S, Angoulvant D, et al. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation 2008;117(13):1701-10
   PubMedGoogle Scholar
• Jia Z, Guo X, Zhang H, et al. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress. Hypertension 2008;52(5):952-9
   PubMedGoogle Scholar
• Kimmel SE, Berlin JA, Reilly M, et al. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med 2005;142(3):157-64
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330(7504):1366
   PubMed Web of Science ®Google Scholar
• Graham DJ. COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA 2006;296(13):1653-6
   PubMed Web of Science ®Google Scholar
• Kerr DJ, Dunn JA, Langman MJ, et al. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 2007;357(4):360-9
   PubMed Web of Science ®Google Scholar
• Brownstein JS, Sordo M, Kohane IS, Mandl KD. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2007;2(9):e840. Published online 5 September 2007, doi:10.1371/journal.pone.0000840
   PubMedGoogle Scholar